Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# CareSet: CareSet transforms Medicare Fee-for-Service claims data into actionable healthcare intelligence. Built on 100% Medicare claims data sourced from CMS, we help pharmaceutical teams understand provider influence, patient journeys, treatment adoption, and market dynamics across the full product lifecycle.

## Sitemaps
[XML Sitemap](https://careset.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [As RPM Use Soars, CMS Proposes Tighter Rules for Third-Party Vendors](https://careset.com/as-rpm-use-soars-cms-proposes-tighter-rules-for-third-party-vendors/): CMS proposed to ban third-party vendors from providing remote patient monitoring services (RPM) and remote therapeutic monitoring (RTM) services on behalf of doctors. The proposed policy could disrupt a rapidly growing Medicare market, where a CareSet analysis found that RPM utilization more than tripled between 2021 and 2025.
- [CAR-T and Bispecific White Paper](https://careset.com/car-t-and-bispecific-white-paper/): Eighteen months ago, CareSet published Did CAR-T's moment pass?, an analysis of Medicare claims from April 2023 through October 2024. That paper documented the early signals of a migration from CAR-T to bispecific therapies and closed with a caveat: trends are signals, and signals can change.
- [Did CAR-T’s moment pass?](https://careset.com/did-car-ts-moment-pass/): Leveraging complete census-level access to monthly Medicare claims, CareSet analyzed datafrom April 2023 to October 2024 to uncover insights into CAR-T and Bispecific therapies,focusing on utilization, growth, referral networks, and opportunities in DLBCL, MM, and ALL.
- [Revolution Medicines’ Breakthrough Drug Doubles Survival in Advanced Pancreatic Cancer](https://careset.com/revolution-medicines-breakthrough-drug-doubles-survival-in-advanced-pancreatic-cancer/): Revolution Medicines’ investigational drug daraxonrasib significantly extended survival for patients with previously treated metastatic pancreatic cancer, according to full results from its phase 3 RASolute 302 trial, confirming topline findings the company first reported in April.
- [ASCO 2026: New Data Highlight Advances in Prostate Cancer Treatments](https://careset.com/asco-2026-new-data-highlight-advances-in-prostate-cancer-treatments/): New research presented at the 2026 ASCO Annual Meeting, held May 29 through June 2 in Chicago, showed that Nubeqa (darolutamide) was associated with potential cognitive benefits compared with Xtandi (enzalutamide), a finding that comes as the drug has already seen rapid uptake among Medicare beneficiaries in recent years, according to a CareSet analysis of Medicare Part D claims.
- [CareSet Data Shows Billions in Medicare Fraud from Catheters](https://careset.com/careset-data-shows-billions-in-medicare-fraud-from-catheters/): By Jinghong Chen
- [Medicare Launches $50 GLP-1 Pilot as Utilization Soars](https://careset.com/medicare-launches-50-glp-1-pilot-as-utilization-soars/): By Jinghong Chen
- [ASCO 2026: Tecvayli Trial Shows Strong Survival Benefit in Multiple Myeloma](https://careset.com/asco-2026-tecvayli-trial-shows-strong-survival-benefit-in-multiple-myeloma/): Among the most closely watched multiple myeloma presentations at the 2026 ASCO Annual Meeting was the phase 3 MajesTEC-9 trial, which found that Tecvayli (teclistamab) significantly improved outcomes over standard therapy. CareSet’s analysis of Medicare claims shows the bispecific antibody has also been the most widely used therapy in its class over the past few years. 
- [How CareSet Data Helped Expose $100M+ in Questionable Medicare Vascular Billing](https://careset.com/how-careset-data-helped-expose-100m-in-questionable-medicare-vascular-billing/): A federal watchdog has confirmed what CareSet’s Medicare data analytics helped uncover years earlier: Medicare paid millions for peripheral vascular procedures that may have been medically unnecessary, with a small group of physicians responsible for a disproportionate share of the billing.
- [Federal Regulators Hand Insurers a Win with Favorable 2027 MA Rate Hike](https://careset.com/federal-regulators-hand-insurers-a-win-with-favorable-2027-ma-rate-hike/): Despite concerns over program integrity and overspending, CMS approved a significantly larger 2027 Medicare Advantage (MA) pay raise than initially proposed, following intense lobbying from the insurance industry.
- [Medicare FFS Improper Payments Top $28B, Fueled by Documentation Gaps, SNFs](https://careset.com/medicare-ffs-improper-payments-top-28b-fueled-by-documentation-gaps-snfs/): Despite years of progress in lowering error rates, traditional Medicare still made more than $28.8 billion in improper payments in the 2025 reporting period. HHS points to documentation failures as the primary driver, while rising error rates in skilled nursing care and durable medical equipment are prompting renewed scrutiny and targeted audits from regulators.
- [SAF vs. RIF: What Every Pharma Exec Needs to Know Before Buying Medicare Insights](https://careset.com/saf-vs-rif-what-every-pharma-exec-needs-to-know-before-buying-medicare-insights/): For pharmaceutical companies, leveraging real-world data is no longer optional—it's essential for everything from health economics and outcomes research (HEOR) to clinical trial acceleration. The Centers for Medicare & Medicaid Services (CMS) is a primary source of this data, but accessing it requires a choice between two main file types: Standard Analytical Files (SAF) and Research Identifiable Files (RIF). Understanding the fundamental differences between them is critical to aligning your data strategy with your research and commercial goals.
- [CareSet Advantage: Pharmaceutical Industry Regulatory Overhaul](https://careset.com/careset-advantage-pharmaceutical-industry-regulatory-overhaul/): Pharmaceutical executives are navigating through an increasingly complex regulatory landscape due to the Inflation Reduction Act (IRA).  It introduced substantial drug cost shifting and now impacts strategic and analytical planning for insurance carriers and drug manufacturers alike. This pivotal legislation brings transparency, and Medicare negotiation to drug pricing, through measures like the 2024 Catastrophic Coverage Cap and a comprehensive overhaul in 2025.
- [Navigating the Maze of Rare Disease Diagnosis: Leveraging Data for Clarity](https://careset.com/navigating-the-maze-of-rare-disease-diagnosis-leveraging-data-for-clarity-2/): ARLINGTON – CareSet released the updated DocGraph HOP Teaming Dataset during the 2022 Health Datapalooza and National Health Policy Conference.
- [Updated DocGraph HOP Teaming PUF Released During Health Datapalooza 2022](https://careset.com/updated-docgraph-hop-teaming-puf-released-during-health-datapalooza-2022/): ARLINGTON – CareSet released the updated DocGraph HOP Teaming Dataset during the 2022 Health Datapalooza and National Health Policy Conference.
- [Regulatory Foreshadowing From JPM Healthcare 2022](https://careset.com/regulatory-foreshadowing-from-jpm-healthcare-2022/): The 40th Annual J.P. Morgan Healthcare Conference, January 10-13, brought strategic insights. This year, I spoke with Deloitte, specifically partners in the regulatory practice and leaders of the regulatory strategies group. This team seeks discussion with healthcare executives who look at the regulatory environment as input to strategy endeavors.As an industry as heavily regulated as healthcare, they approach the legislative and regulatory front from a practice perspective asking four questions: 1: “What are the regulatory white spaces created for stakeholders?” 2: “What regulatory and policy initiatives move against each other vs.
- [HCPCS Code Change Transforms Landscape of Preventative Care](https://careset.com/hcpcs-code-change-transforms-landscape-of-preventative-care/): Until now, healthcare providers spent up to 40% of their time on administrative tasks, largely due to the complexity of the code system. Spending more time on paperwork meant spending less time with patients which was frustrating for everyone.
- [Finding, Treating, and Curing Rare Diseases](https://careset.com/finding-treating-and-curing-rare-diseases-2/): A patient presents with symptoms including numbness, tremors, and occasional weakness, among others. Genetic testing exists to check for rare cardiovascular diseases and defects, but it is expensive and not currently listed as part of the diagnosis protocol. Because of this, his doctors didn’t order the test. He suffered from these symptoms for years before receiving an accurate diagnosis of a rare cardiovascular disease.
- [Transparency in Specialty Pharmacy Supply Chains](https://careset.com/transparency-in-specialty-pharmacy-supply-chains/): Navigating the world of Specialty Pharmacy is complex and riddled with information asymmetry.  But, it just got a lot easier. CareSet provides the experience and unblocked data to connect your new medication with the Specialty Pharmacies and prescribing physicians you need to reach your target patient populations.Characterizing the industry, the co-founder and former president of the National Association of Specialty Pharmacy, and Co-Founder of the Association for Value-Based Cancer Care, Dr. Burt Zweigenhaft, described the industry stating, “The biotech industry is doing a wonderful job, way beyond cancer, in many diseases.  All these drugs are expensive. They are tough to manage. They can’t be on every drug store shelf across America... They are expensive to produce.
- [Unblocking Part D, MarketView](https://careset.com/unblocking-part-d-marketview-2/): In specialty pharmacies, some medications may have partially blocked data. Manufacturers, payers, and specialty pharmacies can elect to block this data. When they do, it’s no longer visible to their allied and competitive healthcare stakeholders, like yourself.
- [CareSet’s Part D Targeting Data Offers Complete Market Transparency](https://careset.com/caresets-part-d-targeting-data-offers-complete-market-transparency/): New Medicare Part D Targeting subscription datasets offer census level accuracy.New Part D Targeting subscription datasets are now available from CareSet to aid pharma marketing decisions.  These datasets supercharge patient’s access to specialty treatments by revealing data that is blocked in commercial datasets.  CareSet receives Part D data two weeks after Medicare approves the data collection, and can deliver insights almost immediately to clients.
- [NCPDP PTI Roundtable for VBA](https://careset.com/ncpdp-pti-roundtable-for-vba/): On 8/30/21, I had the honor of co-chairing the first roundtable from NCPDP's (National Council for Prescription Drug Programs) PharmTechnology Innovation (PTI) Accelerator.  Our presenters discussed the different elements related to value-based agreements (VBA). Our incredible speakers included:
- [Do doctors force their patients to use fax? A CareSet Journal FOIA Whitepaper](https://careset.com/do-doctors-force-their-patients-to-use-fax-a-careset-journal-foia-whitepaper/): Do patients benefit from the money that the U.S. Government has spent on the interoperability of clinical systems? The Centers for Medicare and Medicaid Services (CMS) believes that the purpose of the $34 billion dollar Electronic Health Record (EHR) Incentive Programs (aka “Meaningful Use”), is to provide patients with access to their medical records in digital form.
- [Updated HOP Teaming Dataset Released During PMSA 2021](https://careset.com/updated-hop-teaming-dataset-released-during-pmsa-2021/): The HOP Teaming Dataset from CareSet offers the most detailed and up-to-date picture of the patient-sharing relationships found between all U.S. Medicare providersHOUSTON – CareSet released the updated HOP Teaming Dataset during the Pharmaceutical Management Science Association (PMSA) 2021 Annual Conference. The release is a game-changing dataset that offers the most detailed and up-to-date picture of patient-sharing relationships between all Medicare providers in the US healthcare system.The updated HOP Teaming dataset continues to provide some of the most timely and necessary insights into how healthcare ecosystems work across the US. The HOP Teaming Dataset is also one of the largest social graph datasets of any kind that is available with real person and business names included. This is the sixth year CareSet has released the dataset.
- [CareSet gets accelerated access to Medicare data to perform COVID data analysis](https://careset.com/careset-gets-accelerated-access-to-medicare-data-to-perform-covid-data-analysis/): CareSet is proud to announce that we are now the FIRST (that we know of) company with access to fee-for-service claims data (Part A, B & D), refreshed monthly, and with an industry best 2-week lag. CareSet is using this data to perform analysis of the ongoing COVID pandemic, and how it impacts Medicare patients across the country. This data is the basis for our recent collaboration with the Wall Street Journal on how COVID has impacted Skilled Nursing Facilities across the country.
- [Transparency victories regarding facility-level COVID data](https://careset.com/transparency-victories-regarding-facility-level-covid-data/): HHS has recently released data about vaccinated personnel at different hospitals. They have also released a new “master key” that helps to identify how hospitals are being enumerated as part of the COVID reporting system. Both of these new data resources have been made public as part of the collaboration that CareSet and other data researchers and journalists have with the Federal COVID data team, itself formed with Federal Employees from USDS, the White House and other HHS agency personnel.These data releases are both transparency victories regarding facility-level COVID data. Both new data changes are important enough that our data journalist partners as well as our data clients should be aware of the changes. This data is taken from required and optional data reporting that all hospitals in the US have been supplying to HHS. The first issue is the vaccination rate of healthcare providers. The previous facility-level COVID reporting data has been augmented with 3 new fields:
- [NPI to contact domain data release](https://careset.com/npi-to-contact-domain-data-release/): CareSet Journal is releasing data that links NPI records to the contact domains submitted by providers in their NPI applications. For example, when Jane Smith applied for an NPI, she provided a contact email of "jane.smith@examplehospital.com".
- [Finally Unblinded from the COVID-19 Vaccine Trial](https://careset.com/finally-unblinded-from-the-covid-19-vaccine-trial/): September 2020, I made the decision to participate in one of the SARS-CoV-2 vaccine trials. There is still vaccine hesitancy. My participation in this trial, along with my blog posts, are all in hopes of increasing transparency, and building trust within the trial community. You can follow my journey beginning with my first blog.
- [New Administration, New COVID-19 Federal Datasets](https://careset.com/new-administration-new-covid-19-federal-datasets/): Tune in for a Health Datapalooza Webinar featuring Health and Human Services data leader, hosted by CareSetThe Community Profile Report, a frequently updated national report detailing multiple data streams related to the COVID-19 pandemic, is transforming under the Biden Administration. Learn what this transformation means in relation to transparency of information to the public, and what to expect in data as the roll-out of the vaccines continues.Originally broadcast on February 11, 2021 at 2:00 P.M. ET and featuring Kevin Duvall, Health and Human Services (HHS) Deputy Chief Data Officer and Amy Gleason, Data Strategy and Execution Workgroup Lead, United States Digital Services, in a panel led by Fred Trotter, CTO of CareSet.Trotter led the discussion to examine:
- [Never Before Seen COVID Data Report Released by HHS](https://careset.com/never-before-seen-covid-data-report-released-by-hhs/): (PRNewswire) HOUSTON - Today Health and Human Services (HHS) announced the “COVID Community Profile Report” a daily updated snapshot of how COVID is affecting our states and communities. This release of county-level testing data has never been made available before in any dataset, nor compiled by an outside organization. It is available for public review for the first time.
- [CareSet Collects COVID Collaborators](https://careset.com/careset-collects-covid-collaborators/): Last night, HHS released COVID-19 capacity data at the hospital-level. Previously, this data had only been available on a state level. CareSet had early access to the hospital data in order to help create the Facility COVID PUF Community Frequently Asked Questions document. It is available on our GitHub page. If you have questions about the new capacity data, please create an issue on that GitHub repository. We will answer any questions we can. If there are questions we cannot answer, we will route them through the data team at the WhiteHouse COVID Task Force, who along with HHS and the CDC, maintain the HHS Protect database where this data is stored.
- [HHS Publishes COVID-19 Hospital Facility-Level Data, CareSet to Host Community FAQ](https://careset.com/hhs-publishes-covid-19-hospital-facility-level-data-careset-to-host-community-faq/): (PRWEB) Yesterday the Federal Government released new hospital COVID-19 capacity data at the hospitals-level. Previously released data about hospital capacity had only been released at the state level. The Dept. of Health and Human Services (HHS) provided CareSet with early access to the data in order to facilitate the creation of a community Frequently Asked Questions (FAQ) document, detailing how to work with the new dataset. The community FAQ for this data release is hosted by CareSet on GitHub, and invites healthcare professionals, data journalists, and researchers to ask questions and comment at https://bit.ly/COV-PUF-FAQ.
- [Participating in the COVID-19 vaccine trial part 3](https://careset.com/participating-in-the-covid-19-vaccine-trial-part-3/): I thought it was pertinent I take the chance and sign up for the SARS-CoV-2 vaccine trial. This summer I began my journey. The trial I’m in contains two separate injections several weeks apart. It’s been a month since my second injection. The question remains, am I safe from COVID-19?
- [Participating in the COVID-19 vaccine trial part two](https://careset.com/participating-in-the-covid-19-vaccine-trial-part-two/): Working with life science organizations who create vaccines that help patients, I thought it was apt to immerse myself in the vaccine approval process given the opportunity. I signed up for the SARS-CoV-2 vaccine trial. I wrote about the beginning of this vaccination journey, and below is the first follow-up post of this two-year dedication to science.
- [For science, for the world – participating in the COVID-19 vaccine trial](https://careset.com/participating-in-the-covid-19-vaccine-trial-part-two-2/): Since vaccines are one of CareSet’s specialty areas, I thought it was fitting to jump on the chance to see first-hand what the process of FDA approval is like from a patient’s perspective. So I decided to dedicate the next two years of my life to science.
- [It’s time for tech and biotech to unite — here’s why](https://careset.com/its-time-for-tech-and-biotech-to-unite-heres-why/): Customers always look for ways to make life better. Use this expression as an alternative to the common phrase “new and improved.”
- [COVID-19, Data and Nursing Homes](https://careset.com/covid-19-data-and-nursing-homes/): In my last post, I briefly touched on COVID-19 and older adults. In this post, I will take a short, basic data tour of the skilled nursing home COVID-19 data made available by the CDC.
- [What Does COVID-19 Look Like for Black, Hispanic, and Indigenous People?](https://careset.com/what-does-covid-19-look-like-for-black-hispanic-and-indigenous-people/): Last month, Americans were protesting against the stay-at-home orders in the name of opening the economy as unemployment rates steadily increased. Looking at Twitter, you’ll see many tweets like the one below, pining to reopen. People are aching to go back to “normal.” Looking at data, especially for Black, Hispanic, and Indigenous People, you’ll see that we aren’t in a position to do that just yet.
- [Which Medicare Physician is the Best Doctor to Educate About Your Medication or Medical Device?](https://careset.com/which-medicare-physician-is-the-best-doctor-to-educate-about-your-medication-or-medical-device/): While pharma marketers continue to navigate their brand through COVID-19, non-personal promotion appears to be the best approach for the time being. In order to reach optimal efficiency, marketers will want to utilize the best list of providers for their brand.
- [New Open Data Rules Webinar Recap](https://careset.com/new-open-data-rules-webinar-recap/): On March 9th, 2020, HHS Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services (CMS) finalized two open data rules:
- [Game-changing HOP Teaming Dataset Released To Innovators](https://careset.com/game-changing-hop-teaming-dataset-released-to-innovators-3/): The HOP Teaming Dataset from CareSet offers the most detailed and up-to-date picture of the patient-sharing relationships found between all U.S. Medicare providers
- [Hydroxychloroquine and COVID-19](https://careset.com/hydroxychloroquine-and-covid-19/): People are talking about hydroxychloroquine and coronavirus. And others are looking to grab some for personal use. But what is it, and can it help the thousands of people currently fighting the virus?
- [5 questions every biotech CISO should ask software providers](https://careset.com/5-questions-every-biotech-ciso-should-ask-software-providers/): If you’re the one responsible for keeping track of company meetings, here's everything you need to know about writing effective work ad.
- [CareSet Leads at Health Datapalooza/National Health Policy Conference](https://careset.com/careset-leads-at-health-datapalooza-national-health-policy-conference/): This year Academy Health co-located the National Health Policy Conference with Health Datapalooza. It was well executed. There were lots of great concurrent break-out sessions. Because of that, people had a hard time choosing which health data and policy sessions to attend. Some chose to divide their time between two. This is a high level summary of events from the conference.

## Pages
- [Opt-out preferences](https://careset.com/opt-out-preferences/): This page was last changed on August 14, 2026, last checked on August 14, 2026 and applies to citizens and legal permanent residents of the United States.
- [Data Store](https://careset.com/data-store/): DocGraph began with a FOIA request. When we got access to Medicare data, we chose to release it publicly, and that decision shaped everything we've built since. Whether you're validating treatment sequencing and site-of-care patterns, mapping referral networks, uncovering wait-time disparities and access gaps, or revealing fraud and waste, the data is here. DocGraph is the foundational dataset for non-commercial and commercial uses.
- [Careers](https://careset.com/careers/): CareSet transforms Medicare and Medicaid claims data into actionable insights. Our team brings rigor, curiosity, and a commitment to advancing healthcare.
- [data-journalism-research](https://careset.com/data-journalism-research/): We make Medicare and Medicaid claims data accessible toresearchers, journalists, and policy organizations advancinghealthcare transparency.
- [About-seo-revised](https://careset.com/about/): At CareSet, we believe that open and accessible healthcare data is essential for improving patient outcomes and driving progress in the industry. That’s why we are committed to making this information available to all who need it and why we will continue to advocate for its accessibility in the years to come. CareSet exists to make healthcare data transparent.
- [Solution-seo-revised](https://careset.com/solutions/): For every therapeutic area you work in, we have developed deep TA expertise built on 14 years of granular Medicare claims analysis. We answer the questions your commercial strategy depends on.
- [homepage-seo-revised](https://careset.com/): DUA approved to work with 100% Medicare FFS and MA claims
- [My account](https://careset.com/my-account/): Login Username or email address *Required Password *Required Remember me Log in Lost your password?
- [Checkout](https://careset.com/checkout/)
- [Cart](https://careset.com/cart/): You may be interested in… Your cart is currently empty! New in store
- [Shop](https://careset.com/shop/)
- [Contact Form](https://careset.com/contact-form/): Please fill out the contact form below and we will get back to you soon. Thank you!
- [Insight](https://careset.com/insight/): Analysis written when the data has something worth saying. We publish based on substance rather than volume, for pharmaceutical commercial teams, policy audiences, and the public interest community.

## Products
- [DocGraph Same Day (2023)](https://careset.com/product/docgraph-same-day-2023/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Same Day (2024)](https://careset.com/product/docgraph-same-day-2024/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Same Day (2025)](https://careset.com/product/docgraph-same-day-2025/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2025)](https://careset.com/product/docgraph-annual-2025/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual (2015)](https://careset.com/product/docgraph-annual-2015/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2014)](https://careset.com/product/docgraph-annual-same-day-2014/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Same Day (2014)](https://careset.com/product/docgraph-same-day-2014/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2014)](https://careset.com/product/docgraph-annual-2014/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual (2023)](https://careset.com/product/docgraph-annual-2023/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual (2024)](https://careset.com/product/docgraph-annual-2024/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Same Day (2017)](https://careset.com/product/docgraph-same-day-2017/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2017)](https://careset.com/product/docgraph-annual-2017/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2016)](https://careset.com/product/docgraph-annual-same-day-2016/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Same Day (2016)](https://careset.com/product/docgraph-same-day-2016/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2016)](https://careset.com/product/docgraph-annual-2016/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2015)](https://careset.com/product/docgraph-annual-same-day-2015/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Same Day (2015)](https://careset.com/product/docgraph-same-day-2015/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Same Day (2019)](https://careset.com/product/docgraph-same-day-2019/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2019)](https://careset.com/product/docgraph-annual-2019/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2018)](https://careset.com/product/docgraph-annual-same-day-2018/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Same Day (2018)](https://careset.com/product/docgraph-same-day-2018/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2018)](https://careset.com/product/docgraph-annual-2018/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2017)](https://careset.com/product/docgraph-annual-same-day-2017/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Annual + Same Day (2021)](https://careset.com/product/docgraph-annual-same-day-2021/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Same Day (2021)](https://careset.com/product/docgraph-same-day-2021/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2021)](https://careset.com/product/docgraph-annual-2021/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2020)](https://careset.com/product/docgraph-annual-same-day-2020/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Same Day (2020)](https://careset.com/product/docgraph-same-day-2020/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2020)](https://careset.com/product/docgraph-annual-2020/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph Annual + Same Day (2019)](https://careset.com/product/docgraph-annual-same-day-2019/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Annual + Same Day (2025)](https://careset.com/product/docgraph-annual-same-day-2025/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Annual + Same Day (2024)](https://careset.com/product/docgraph-annual-same-day-2024/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Annual + Same Day (2023)](https://careset.com/product/docgraph-annual-same-day-2023/): The complete picture: full-year referral network plus the same-day acute-care collaboration layer.
- [DocGraph Annual + Same Day (2022)](https://careset.com/product/docgraph-annual-same-day-2022/)
- [DocGraph Same Day (2022)](https://careset.com/product/docgraph-same-day-2022/): Providers billing the same patient on the same calendar day — the acute-care collaboration layer.
- [DocGraph Annual (2022)](https://careset.com/product/docgraph-annual-2022/): Full-year patient-sharing across the entire Medicare FFS population. The complete referral network.
- [DocGraph (2019) Non-Commercial](https://careset.com/product/docgraph-2019-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2018) Non-Commercial](https://careset.com/product/docgraph-2018-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2017) Non-Commercial](https://careset.com/product/docgraph-2017-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2016) Non-Commercial](https://careset.com/product/docgraph-2016-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2015) Non-Commercial](https://careset.com/product/docgraph-2015-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2014) Non-Commercial](https://careset.com/product/docgraph-2014-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2024) Non-Commercial](https://careset.com/product/docgraph-2024-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2023) Non-Commercial](https://careset.com/product/docgraph-2023-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2022) Non-Commercial](https://careset.com/product/docgraph-2022-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2021) Non-Commercial](https://careset.com/product/docgraph-2021-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.
- [DocGraph (2020) Non-Commercial](https://careset.com/product/docgraph-2020-non-commercial/): Full-year patient-sharing across the entire Medicare FFS population, licensed for academic and research use.

## Custom Dashboard
- [Custom TO Dashboard](https://careset.com/uicore-cd/ui-cd-to/)
- [Custom WP Dashboard](https://careset.com/uicore-cd/ui-cd-wp/)

## Theme Builder
- [Biotech Company – Footer](https://careset.com/?uicore-tb=biotech-company-footer): CareSet transforms Medicare Fee-for-Service claims data into actionable healthcare intelligence. Built on 100% Medicare claims data sourced from CMS, we help pharmaceutical teams understand provider influence, patient journeys, treatment adoption, and market dynamics across the full product lifecycle.